| Description |
1 online resource (xi, 368 pages) |
| Contents |
Preface -- Introduction -- Leadership -- Starting Right -- Ethics in an Emerging Field -- Getting Advice -- Self-Assessment -- Endnotes |
| Summary |
This book is the first systematic, detailed treatment of the approaches to ethical issues taken by biotech and pharmaceutical companies. The application of genetic/genomic technologies raises a whole spectrum of ethical questions affecting global health that must be addressed. Topics covered in this comprehensive survey include considerations for bioprospecting in transgenics, genomics, drug discovery, and nutrigenomics, as well as how to improve stakeholder relations, design ethical clinical trials, avoid conflicts of interest, and establish ethics advisory boards. The expert authors represent multiple disciplines including law, medicine, bioinformatics, pharmaceutics, business, and ethics |
| Notes |
Includes index |
| Bibliography |
Includes bibliographical references and index |
| Notes |
Print version record |
| Subject |
Biotechnology industries -- Moral and ethical aspects -- Case studies
|
|
Pharmaceutical industry -- Moral and ethical aspects -- Case studies
|
|
Business ethics -- Moral and ethical aspects -- Case studies
|
|
Bioethics.
|
|
Business ethics -- Case studies
|
|
Bioethics
|
|
Biotechnology -- ethics
|
|
Drug Industry -- ethics
|
|
Ethics, Business
|
|
BUSINESS & ECONOMICS -- Business Ethics.
|
|
Business ethics
|
|
Bioethics
|
|
Biotechnology industries -- Moral and ethical aspects
|
|
Pharmaceutical industry -- Moral and ethical aspects
|
| Genre/Form |
dissertations.
|
|
Case studies
|
|
Case studies.
|
|
Academic theses.
|
|
Études de cas.
|
|
Thèses et écrits académiques.
|
| Form |
Electronic book
|
| Author |
Finegold, David.
|
| ISBN |
9780123693709 |
|
0123693705 |
|
9780080492513 |
|
0080492517 |
|
1281005339 |
|
9781281005335 |
|
